These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19249524)

  • 1. In situ quantitative immunoprofiling of regulatory T cells using laser scanning cytometry.
    Takahashi H; Ruiz P; Ricordi C; Miki A; Mita A; Barker S; Tzakis A; Ichii H
    Transplant Proc; 2009; 41(1):238-9. PubMed ID: 19249524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative in situ analysis of FoxP3+ T regulatory cells on transplant tissue using laser scanning cytometry.
    Takahashi H; Ruiz P; Ricordi C; Delacruz V; Miki A; Mita A; Misawa R; Barker S; Burke GW; Tzakis AG; Ichii H
    Cell Transplant; 2012; 21(1):113-25. PubMed ID: 21929847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
    Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
    J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells.
    Law JP; Hirschkorn DF; Owen RE; Biswas HH; Norris PJ; Lanteri MC
    Cytometry A; 2009 Dec; 75(12):1040-50. PubMed ID: 19845018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.
    Yip WK; Abdullah MA; Yusoff SM; Seow HF
    Clin Exp Immunol; 2009 Mar; 155(3):412-22. PubMed ID: 19220831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
    Robb RJ; Lineburg KE; Kuns RD; Wilson YA; Raffelt NC; Olver SD; Varelias A; Alexander KA; Teal BE; Sparwasser T; Hammerling GJ; Markey KA; Koyama M; Clouston AD; Engwerda CR; Hill GR; MacDonald KP
    Blood; 2012 Jun; 119(24):5898-908. PubMed ID: 22538855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
    Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
    Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic overexpression of heme oxygenase-1 improves liver allograft survival by expanding T regulatory cells.
    Sun L; Shi T; Qiao H; Jiang X; Jiang H; Krissansen GW; Sun X
    J Surg Res; 2011 Apr; 166(2):e187-94. PubMed ID: 21227452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease.
    Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A
    Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of tissue FoxP3+, CD4+ and CD8+ T-cells in active and stable nonsegmental vitiligo.
    Abdallah M; Lotfi R; Othman W; Galal R
    Int J Dermatol; 2014 Aug; 53(8):940-6. PubMed ID: 24527781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DC expressing transgene Foxp3 are regulatory APC.
    Lipscomb MW; Taylor JL; Goldbach CJ; Watkins SC; Wesa AK; Storkus WJ
    Eur J Immunol; 2010 Feb; 40(2):480-93. PubMed ID: 19941313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.
    Liu T; Soong L; Liu G; König R; Chopra AK
    Biol Direct; 2009 Oct; 4():40. PubMed ID: 19852824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
    Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis.
    Semple PL; Binder AB; Davids M; Maredza A; van Zyl-Smit RN; Dheda K
    Am J Respir Crit Care Med; 2013 Jun; 187(11):1249-58. PubMed ID: 23590266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in Psoriasis.
    Bovenschen HJ; van Vlijmen-Willems IM; van de Kerkhof PC; van Erp PE
    Dermatology; 2006; 213(2):111-7. PubMed ID: 16902287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare development of Foxp3+ thymocytes in the CD4+CD8+ subset.
    Lee HM; Hsieh CS
    J Immunol; 2009 Aug; 183(4):2261-6. PubMed ID: 19620303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute a unique cell subset.
    Kuczma M; Podolsky R; Garge N; Daniely D; Pacholczyk R; Ignatowicz L; Kraj P
    J Immunol; 2009 Sep; 183(6):3731-41. PubMed ID: 19710455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications.
    Di Ianni M; Del Papa B; Cecchini D; Bonifacio E; Moretti L; Zei T; Ostini RI; Falzetti F; Fontana L; Tagliapietra G; Maldini C; Martelli MF; Tabilio A
    Clin Exp Immunol; 2009 May; 156(2):246-53. PubMed ID: 19292855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
    Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
    Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4
    Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
    Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.